Insider Trading Activity Edge Therapeutics Inc (NASDAQ:EDGE) – CEO Sold 2,500 shares of Stock

ME Staff
-
0

Insider Trading Activity For Edge Therapeutics Inc (NASDAQ:EDGE)

Brian A Leuthner , CEO of Edge Therapeutics Inc (NASDAQ:EDGE) reportedly Sold 2,500 shares of the company’s stock at an average price of 14.81 for a total transaction amount of $37,025.00 SEC Form

Insider Trading History For Edge Therapeutics Inc (NASDAQ:EDGE)

  • On 10/6/2015 James Healy, Director, bought 450,000 with an average share price of $11.00 per share and the total transaction amounting to $4,950,000.00.
  • On 10/6/2015 Andrew J. Einhorn, CFO, bought 45,000 with an average share price of $11.00 per share and the total transaction amounting to $495,000.00.
  • On 3/11/2016 James Healy, Director, bought 541,343 with an average share price of $7.30 per share and the total transaction amounting to $3,951,803.90.
  • On 8/1/2016 Brian A Leuthner, Insider, sold 7,500 with an average share price of $9.54 per share and the total transaction amounting to $71,550.00.
  • On 8/8/2016 W Bradford Middlekauff, VP, bought 10,000 with an average share price of $9.48 per share and the total transaction amounting to $94,800.00.
  • On 10/3/2016 Brian A Leuthner, Insider, sold 7,500 with an average share price of $10.25 per share and the total transaction amounting to $76,875.00.
  • On 12/1/2016 Brian A Leuthner, Insider, sold 7,500 with an average share price of $11.60 per share and the total transaction amounting to $87,000.00.

    • Analyst Ratings History For Edge Therapeutics Inc (NASDAQ:EDGE)

    • On 3/9/2016 JMP Securities Lower Price Target of rating Market Outperform with a price target of $34.00 to $18.00
    • On 3/3/2017 Guggenheim Reiterated Rating Buy to In-Line with a price target of $30.00
    • On 3/3/2017 Leerink Swann Reiterated Rating Outperform to Outperform with a price target of $21.00
    • On 1/18/2018 Credit Suisse Group Reiterated Rating Outperform to Outperform with a price target of $17.00

    Recent Trading Activity for Edge Therapeutics Inc (NASDAQ:EDGE)
    Shares of Edge Therapeutics Inc closed the previous trading session at with 15.350000381469727 shares trading hands.